The American Society of BioMedicine (ASBM) Medical and Scientific Advisory Board is comprised of leading experts in their fields. Board members volunteer their time to (ASBM) and receive no compensation for their generous support.
The Medical and Scientific Advisory Board’s role is to advise the Board of Directors on a range of issues. These include periodically reviewing ASBM’s medical affairs and recommending post doctorate fellowship.
Board Members
Jay Bradner, M.D.
Dana-Farber Cancer Institute
Steven Bernstein, M.D.
University of Rochester Medical Center
Department of Medicine
Alexandra Mayes Birnbaum
Peartree Communications, Inc.
Jim Davis, Ph.D., J.D.
Former Human Genome Sciences
Alan D. D’Andrea, M.D.
Dana-Farber Cancer Institute
Co-Director, Gene Therapy Center
Sandra J. Horning, M.D.
Genentech, Inc.
Catriona Jamieson, M.D., Ph.D.
The Regents of the University of California, San Diego
Stem Cell Research Program
Jonathan D. Licht, M.D.
Northwestern University Feinberg School of Medicine
Division of Hematology/Oncology
Johanna Dobe Professor & Chief
Alan F. List, M.D.
H. Lee Moffit Cancer Center & Research Institute
Ross Levine, M.D.
Memorial Sloan-Kettering Cancer Center
Susan M. O’Brien, M.D.
The University of Texas, M.D. Anderson Cancer Center
Department of Leukemia
Hassan Abdul Amir Al-Daghir, M.D.
Department of Medicine, Al-Hussein teaching hospital, Al-Muthanna